Viewing Study NCT07085169


Ignite Creation Date: 2025-12-24 @ 10:47 PM
Ignite Modification Date: 2026-04-01 @ 2:14 PM
Study NCT ID: NCT07085169
Status: RECRUITING
Last Update Posted: 2025-07-25
First Post: 2025-07-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Low-dose Trifluridine/Tipiracil With Bevacizumab in mCRC
Sponsor: Ruijin Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module